COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single infusion of COVID-Fighting antibodies keep High-Risk patients out of the hospital?
Disease control TerminatedThis study tests whether a single infusion of hyperimmune immunoglobulin (hIVIG) — concentrated antibodies from recovered COVID-19 patients — can help adults at high risk (age 55+ or with weakened immune systems) who have early COVID-19. Participants receive either the antibody i…
Matched conditions: COVID
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
Promising COVID-19 treatment trial pulled before it began
Disease control TerminatedThis study was designed to test whether an inhaled drug called ZYESAMI could help people with severe COVID-19 avoid getting worse and needing a ventilator. It was a Phase 3 trial, meaning it was in the final stage of testing. However, the study was withdrawn before any participan…
Matched conditions: COVID
Phase: PHASE3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
COVID plasma trial pulled before it even started
Disease control TerminatedThis study planned to give blood plasma from recovered COVID-19 patients to people in the ICU with severe COVID-19. The goal was to see if it could help them breathe better and survive. However, the trial was withdrawn before enrolling any participants, so no results are availabl…
Matched conditions: COVID
Phase: PHASE1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
COVID-19 drug study pulled before it even started
Disease control TerminatedThis study aimed to see if the drug sarilumab could help hospitalized COVID-19 patients with severe breathing distress. It planned to compare one or two doses of sarilumab against a placebo. However, the study was withdrawn before enrolling any participants, so no results are ava…
Matched conditions: COVID
Phase: PHASE2 • Sponsor: BayCare Health System • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
What happens to severe COVID-19 survivors after the ICU?
Knowledge-focused OngoingThis study follows 90 people who survived severe COVID-19 pneumonia and needed intensive care. Researchers will check their physical health, mental health, and quality of life at 3 months, 6 months, 1 year, and 5 years after leaving the ICU. The goal is to better understand the l…
Matched conditions: COVID
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists create COVID-19 biobank to unlock disease secrets
Knowledge-focused OngoingThis study collects blood samples and medical information from 201 adults diagnosed with COVID-19. The goal is to create a resource that researchers can use to study the virus and improve understanding of the disease. Participants provide samples and allow their health data to be…
Matched conditions: COVID
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC